{"name":"Ethical Oncology Science","slug":"ethical-oncology-science","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNQWtwd0pVNjdPVTA4SHNQZXdJU3lKaTllVkd6Tzc2NnJGLVhITTRZU0x5RF9jT2c1SENZUVBFVVhEQURMQW5GaFBiOEEwaG82VmNVS2ZaNzh4ODJFRThHX042S2kyU2NUT1dSUFAxczlTbHpnOFhPWjZ5aS1UQWg3bkYzOFE1UEp6R2xVdm9oT0xELXFlcTR6ajhFcGNNUW5WblpRdFpNTzBHUFFJZktaTHRrQXByeklwZHg4?oc=5","date":"2026-04-02","type":"trial","source":"Oncology News Central","summary":"From Trial Failures to Fraud Charges: Oncology Industry Challenges in Focus - Oncology News Central","headline":"From Trial Failures to Fraud Charges: Oncology Industry Challenges in Focus","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTFBLLXpVeUZabXFOZWNGdzl1djB2MHRpVnpNVTBRY212cE1jdmMtWGpabHJ1MVZWXzVUSkNIOHhObkc3V2drQm1oaW8yN2psVWQxWVhaYVBuZ0tkRmNmSlE?oc=5","date":"2026-03-31","type":"trial","source":"Science Partner Journals","summary":"Rezivertinib in EGFR -Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study - Science Partner Journals","headline":"Rezivertinib in EGFR -Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervou","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPdlRjTzF6ZE5TX1ZKeG1KSHhvakxFWC1IV1NGeXg2ZUdSNzhaZnRrZ0ZwNGZ1bkpLYndSQnAyV1IxV1FWMmRnYW95djR5V18wR3FfNHI0TXIxdkVNM3BKRENVdVc5cTJ2a1pfMkFwLXlCVlJOQXlPUXp0RTdyX18tTzJEa21sYVZKVGZQMmhFVE85SkU2SEFBNDQ3TUJKbGpZc1hOYlVlWFl0UGVWVnAxbUQ3bw?oc=5","date":"2026-03-26","type":"trial","source":"Oncology News Central","summary":"What’s in a Name? The Ethics and Psychology of Oncology Trial Acronyms - Oncology News Central","headline":"What’s in a Name? The Ethics and Psychology of Oncology Trial Acronyms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNLWx3TG1rT1pHMGJrUHVBaFZFejlnRUNHUW4ycVRRWmR3STlqWGtwNGFYWlQ1a3NRaVNMWS0ta0tRNHRJYnBGQkRMaEZwc1BFNks5WF9VUGxuZDlucTdhZ1JTUm1QdFhrTFR2VTR2NlRvd2FDNjhRTE43OENNWlJ6OWFxYk95bW9rQlJ3Rg?oc=5","date":"2026-02-12","type":"pipeline","source":"The Motley Fool","summary":"Top Cancer Stocks for 2026 and How to Invest - The Motley Fool","headline":"Top Cancer Stocks for 2026 and How to Invest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPZmFJSm95ejBDQlYxMTNUSDRXMHcwZ0pUWEd1ZVdpbFcwdUM5NERxUUpvRTB6NFBZVzh0WldqN0ZMTk9YWUtfUG1QZDZ5dDFFRGktajBYY3JGbzVGcUZOT0cybkJBOVdpTGpxRlBpbThET0dOQXE5elVPRy0yMkNvV3dabGxIQVVKQzU5WEpfdFBWMXh1alNkTXNZcnhXOWhtQ0t4VldlazRYb19Fb09BQWN3aGI?oc=5","date":"2026-01-27","type":"trial","source":"statnews.com","summary":"Sidelining Black women in clinical trials is not just a moral failure. It’s bad science - statnews.com","headline":"Sidelining Black women in clinical trials is not just a moral failure. It’s bad science","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOQmZHWm9qNnp3SlVPcHV6N0F3Rl9ZTkpkZDVMSWZ3bVNINy1Ickl2SnQ1RHh5dHliTGJualJHYkphZ01zemZXYXRNR2VSR0FZNHlHdzhyQ1hqV3I2YjdiSTZoMXB5OWFDeGpKMlNHSHhVVk5zeTVBYUw2OE9CRkEzYS1sVVpBSWREY0VfVFJxcUdFN213ZGFISncySQ?oc=5","date":"2025-12-17","type":"pipeline","source":"The Guardian","summary":"Why does big pharma pay doctors? It raises an important question about healthcare ethics | Ranjana Srivastava - The Guardian","headline":"Why does big pharma pay doctors? It raises an important question about healthcare ethics | Ranjana Srivastava","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTFBxSG4xeHVhSzJyam9UVDdmMDV0YWlYNGMzS0NKeG9ESmNMTDlybEFFdFFwMElFMkhJT0JGaVJxTk1ITWJackFrUjdLOHZZZnVwMTkzeGl2RGN5ZTBwNU11Qk43a1RtcEQ0Q0ZOdmVEYW1kaUk?oc=5","date":"2025-12-16","type":"trial","source":"Bloomberg.com","summary":"Cancer Doctors Are Making a Fortune Off Drug-Trial Participants - Bloomberg.com","headline":"Cancer Doctors Are Making a Fortune Off Drug-Trial Participants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPN0ZkaFpsTmpjbTc1MERQa0o3M3ZNU0NWME9ZS29mWXlMZGk5NkNyR3JNUkpUNzljc181cjVQdnRYS0paNlJ6Vm1MQkxyU2k2cEZkRFBCQkRUOG50c1haN2pueDZVeklidWFkRkpxLVNIZWhsOGFFM3dFbEhCRGMzZ0JKcHNHajVyRng4REc2RFFXdGRobTE2YmQydXcxdFZKSGdVWmdZbjFITW5LaWN1azhicXBmUQ?oc=5","date":"2025-10-30","type":"trial","source":"Oncology News Central","summary":"“Ethically Troubling” Cancer Drug and Test Use After Trial Participation? - Oncology News Central","headline":"“Ethically Troubling” Cancer Drug and Test Use After Trial Participation?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFB4YXlqQ1FUelI4S04wRUNrbWlJSGpDbUNWQ2F3MWhTbUNlR0xEN1cxa0pNVndGQXl1Uk1mbG5fWmZudHdXY085N25tTnlTdGhRWVVXVENhUkF0U0xKRTZJ?oc=5","date":"2025-10-20","type":"pipeline","source":"nature.com","summary":"Unlocking the potential: multimodal AI in biotechnology and digital medicine—economic impact and ethical challenges - nature.com","headline":"Unlocking the potential: multimodal AI in biotechnology and digital medicine—economic impact and ethical challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPTGdIWXh4V1BaZ2UwV0hOa20tbG43NzFNR0NtZ0M5ZVFfeklYbTgyRmpRcFJfbnFOeTU5V21PMFhyNVc4cG53OEl2ZkFibzM5SFlTUXdXdTY3ZXZnU294NHl0QURYZlM1OTRIMzZRWWdoeFFSQjFoWTNMWm5DNVAxQkxGUjc2bmtya2dxUW5WSXJYRlFTVjJZLTVn?oc=5","date":"2025-07-23","type":"pipeline","source":"Frontiers","summary":"A review on integrative approaches in oncology: bridging ayurvedic medicine and modern cancer therapeutics - Frontiers","headline":"A review on integrative approaches in oncology: bridging ayurvedic medicine and modern cancer therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQcnB1SkVWZ3dpZ1BMTnp3UXJ3SE1ZWWlWb1NoNjd5bG5nRUd0WWM0T01ucVctWjBuYnRoOS1TN20yVTZ4a2ZfSTAydHAxbXJ5eEROaC1tako1M3V5RlhSNDVYcE5acnRGbDZwTFdkZ0NTMGpMVHBfZlAwSWxoN1Rmanp0VG9TdDctVTQ2SFhiYVpLQmFiUndqb1VScnlxUQ?oc=5","date":"2025-07-17","type":"pipeline","source":"Klover.ai","summary":"AstraZeneca’s AI Strategy: Analysis of AI Dominance in Pharmaceutical and Biotech - Klover.ai","headline":"AstraZeneca’s AI Strategy: Analysis of AI Dominance in Pharmaceutical and Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQVXBvcERydl9BbGdSRjYxYXdkY0VacHZaZWZRRGNQa0swbEluZm1WQmhnT203ZklvLS1XdmRlcDhSRWNmdzRQZk50OFY0QV94TnVsbVhiQVhxNm5ETkZQUGEyelg0cE1qblBhX2tWVUdqRjdyZV9uUE9YQW96UmhucFFZVnpMbkxoSWJleA?oc=5","date":"2024-04-10","type":"pipeline","source":"Pharmacy Times","summary":"Approaching Ethical Dilemmas in Oncology Pharmacy - Pharmacy Times","headline":"Approaching Ethical Dilemmas in Oncology Pharmacy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}